1. Home
  2. QTRX vs HCAT Comparison

QTRX vs HCAT Comparison

Compare QTRX & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.71

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$2.08

Market Cap

168.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
HCAT
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Computer Software: Programming Data Processing
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
168.5M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
QTRX
HCAT
Price
$3.71
$2.08
Analyst Decision
Hold
Hold
Analyst Count
2
10
Target Price
$6.00
$2.53
AVG Volume (30 Days)
747.3K
1.3M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,632,000.00
$311,136,000.00
Revenue This Year
$25.49
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
64.52
1.48
52 Week Low
$2.40
$0.96
52 Week High
$8.77
$4.12

Technical Indicators

Market Signals
Indicator
QTRX
HCAT
Relative Strength Index (RSI) 47.36 51.76
Support Level $3.30 $2.02
Resistance Level $3.81 $2.39
Average True Range (ATR) 0.32 0.10
MACD -0.06 -0.05
Stochastic Oscillator 9.37 13.16

Price Performance

Historical Comparison
QTRX
HCAT

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: